New automated sedation system aims to use less medicine in ICU
NCT ID NCT06187545
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested a prototype device that automatically gives the sedative propofol to deeply sedated patients in the ICU who are on breathing machines. The goal was to see if the device could keep patients at the right sedation level while using less medication compared to usual care. Twenty patients took part, and the study compared the amount of propofol used and sedation levels between the two approaches.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- propofol
- What this could lead to
- If it works, this could lead to a smarter way to sedate ICU patients, using less medication and possibly reducing side effects.
- What could go wrong
- This is a very small pilot study with only 20 patients, so results may not apply to everyone. The device is still a prototype and may not work better than usual care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Indication of deep sedation for more than 48 hours Exclusion Criteria: * Dementia * Cranial surgery * Hypoxic-ischemic encephalopathy * Chronic liver damage Child C * History of substance and drug abuse that can alter EEG recordings or the metabolization of drugs (antipsychotics, cocaine, benzodiazepines, opioids) * Pregnant women * allergic to propofol * EEG sensor of the BIS® Covidien cannot be installed
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Deep sedation are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile
Santiago, RM, 7690306, Chile
-
Hospital Base San José Osorno
Osorno, Los Lagos Region, Chile
-
Hospital Clinico de la Universidad de Chile
Santiago, RM, 7690306, Chile
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Easier sedation for heart ablation: safer and more comfortable?
- Oxygen flow study aims to boost safety during bladder scope sedation
- Which airway method keeps oxygen levels safer during hysteroscopy sedation?
- Brain monitor may improve sedation safety for heart shock procedure
- New model aims to perfect sedation dosing
- New study aims to make dental sedation safer and more comfortable